Flo

At Flo Health, our purpose is to build a better future for female health. We are the world’s leading period and ovulation tracker, empowering over 400 million women globally to take control of their health. With 77 million monthly active users, including 25% of US women, Flo has become a trusted partner in women's health. As the first European femtech unicorn, following a $230M Series C in July 2024, we're proud to lead the way in innovation and investment in women's health. With over 100+ medical experts, Flo is committed to supporting women at every stage of their health journey, from menstruation to conception, pregnancy, and menopause. We provide curated cycle and ovulation tracking, tailored health insights, daily bite-sized visual content, and a private community for users to share their questions and concerns. Flo addresses critical challenges in women’s health by: *Expanding access: Through partnerships like UNFPA, Flo provides free Premium access to up to 1 billion women in 66 countries, with 17 million subscriptions donated, helping bridge healthcare disparities.

Founded

2015

Company size

201-500

Headquarters

London, England, GB

Funding

Series C